APM Terminals and Compañia de Puertos Asociados S.A. (Compas S.A.), a Colombian-based port and terminal operating company, recently signed a joint venture agreement to operate Compas S.A.'s existing multipurpose Cartagena Terminal together.
“Colombia represents one of the most promising investment opportunities in the region
and we are pleased to participate in the country’s ongoing economic growth and
development,” APM Terminals CEO Kim Fejfer said. “Cartagena has enormous significance in South America ports and this JV underlines APM Terminals' growth and investment plans.”
APM Terminals and Compas S.A. will jointly invest more than $200 million in upgrading
and expanding the Cartagena Terminal, including state-of-the-art terminal equipment.
The upgrade will triple annual throughput capacity for the terminal to handle the larger
vessels going through the widened Panama Canal.
Compas S.A. will continue to be the concession holder and APM Terminals will hold a
51 percent majority share in the joint venture that will run the facility.
“Compas S.A. has the service reputation and expertise in Cartagena and Colombia that
ideally fits our Latin America partner strategy and port development ambitions,” Joe
Nicklaus Nielsen, APM Terminals vice president and global head of container business
development, said. “We look forward to working with them on developing the Cartagena terminal further.”
Organizations in this story
APM Terminals Coloradoweg 50 Maasvlakte Rotterdam, ZH - 3199 LA
- New Colombia Resources says Sannabis test was successful
- Grupo Exito aims to help support Colombia
- Codelco CEO calls for transparency, focus on production goals
- BCP offers tips on choosing master's degree program
- General Tire launches new tire for Andean market
- Latin America talks of boosting pork production, exports @CorferiasBogota
- AIR Worldwide team takes part in wind-engineering conference
- El Salvador's Asesuisa discusses risk management, strategic direction with stakeholders
- Grupo Exito buying lettuce locally to support resocialization program
- Endo selling Mexico-based Grupo-Farmaceutico Somar